Your Most Trusted Partner Since 1946
Home
About Us
Vision & Mission
Milestones
Achievements & Awards
Our Team
Products
Injectables
Antibiotics
3Zone-s
Augnex
Aztranex
Cefzinex A
Clarinex
Clistril
D-Cycline
Fosfonex
Pipnex
Teiconex
Tigacin
Metronex
Minonex
Nexicef-S
Nexinem
Neximyx-B
Nexinem-S
Nexivan
Roxinex
Sulbanov
Anticoagulant
Enoclot
Novohep
Antimalarial
Artekill
Antioxidants
Ascovit-C
Gluthnex
Lolarin
Antipyretic
Neximol
Cardiovascular
Adbeat
Adrenex
Dobutrig
Dopatrig
Esmonorm
Labenex
Milrisafe
Miodar
Nexiter
Nitronex
Norex
Pressinex
Central Nervous System
Atracunex
Edarnex
Levenex
Novocit
Piratem
Corticosteroids
Cortinex
Succinex-M
Gastro
Esmonex
Octronex
Panonex
Other
Nexiran
Fecarnex
Fibtran
mumix
Nexizost
Nexthiam
O2Rise
Pediatric Oral
Antibiotic
Nexiclox DS
Nutraceuticals
Nexi D3
Vaccine
Nexipox Advance PFS
Pipeline
Business
Domestic
International
News & Events
Information Corner
News Room
Public Awareness Campaign
Public Information
Testimonial
Careers
Contact Us
Inspired By Value, Driven By Vision
Patience, Perseverance & Visionary Growth Strategy
Public Information
In an exclusive interview with Biospectrum India, our Managing Director, Forum Bhagat, shares insights on Novo Medi Science’s latest achievements, upcoming plans for 2025 and commitment to advancing healthcare solutions.
Novo Medi Sciences shaping the future of preventive healthcare
On this World Quality Day, we are thrilled to share the exclusive interview featuring Ms. Forum Bhagat, Managing Director of Novo Medi, with Dr. Asawari Savant
